A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
Morris
R E
RE
Department of Cardiovascular Surgery, Stanford University School of Medicine, CA 94305-5247.
Wu
J
J
Shorthouse
R
R
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D011090:Polyenes / Q000627:therapeutic use; D020123:Sirolimus; D016559:Tacrolimus; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus; D016559:Tacrolimus